{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:17:09Z","timestamp":1772763429977,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ejpn-journal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejpn.2024.09.005","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T21:32:57Z","timestamp":1726608777000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Early differential diagnosis between acute inflammatory demyelinating polyneuropathy and acute-onset chronic inflammatory demyelinating polyneuropathy in children: Clinical factors and routine biomarkers"],"prefix":"10.1016","volume":"53","author":[{"given":"Zhiwei","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiannan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8513-5446","authenticated-orcid":false,"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejpn.2024.09.005_bib1","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s13311-021-01117-3","article-title":"Novel immunological and therapeutic insights in guillain-barr\u00e9 syndrome and CIDP","volume":"18","author":"Querol","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.ejpn.2024.09.005_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of guillain-barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ejpn.2024.09.005_bib3","article-title":"Incidence of Guillain-Barr\u00e9 syndrome (GBS) in China: a national population-based study","volume":"18","author":"Zheng","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"issue":"3\u20134","key":"10.1016\/j.ejpn.2024.09.005_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000494291","article-title":"Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis","volume":"52","author":"Broers","year":"2019","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1016\/j.ejpn.2024.09.005_bib5","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209130","article-title":"Prevalence, clinical profiles, and prognosis of CIDP in Japanese nationwide survey: analyses of 1,257 diagnosis-confirmed patients","volume":"102","author":"Aotsuka","year":"2024","journal-title":"Neurology"},{"issue":"10280","key":"10.1016\/j.ejpn.2024.09.005_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ejpn.2024.09.005_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bunschoten","year":"2019","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.ejpn.2024.09.005_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp-2019-322479","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome","volume":"91","author":"Koike","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"23","key":"10.1016\/j.ejpn.2024.09.005_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0000000000006625","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in CIDP","volume":"91","author":"Koike","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ejpn.2024.09.005_bib10","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force\u2014second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.ejpn.2024.09.005_bib11","article-title":"Corticosteroids for guillain-barr\u00e9 syndrome","volume":"2016","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejpn.2024.09.005_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16073","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of guillain-barr\u00e9 syndrome","author":"van Doorn","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"21","key":"10.1016\/j.ejpn.2024.09.005_bib13","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Dutch GBS Study Group Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study","volume":"74","author":"Ruts","year":"2010","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ejpn.2024.09.005_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.braindev.2015.04.001","article-title":"Childhood CIDP: study of 31 patients and comparison between slow and rapid-onset groups","volume":"37","author":"Cabasson","year":"2015","journal-title":"Brain Dev-Jpn"},{"key":"10.1016\/j.ejpn.2024.09.005_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.667378","article-title":"Pediatric CIDP: diagnosis and management. A single-center experience","volume":"12","author":"\u0141ukawska","year":"2021","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.09.005_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jns.12266","article-title":"Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients","volume":"23","author":"Alessandro","year":"2018","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ejpn.2024.09.005_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16222","article-title":"A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy","author":"Zhang","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.ejpn.2024.09.005_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/mus.21480","article-title":"Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy","volume":"41","author":"Dionne","year":"2010","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ejpn.2024.09.005_bib19","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1007\/s00415-023-11559-8","article-title":"A meta-analysis on the prevalence of Charcot\u2013Marie\u2013Tooth disease and related inherited peripheral neuropathies","volume":"270","author":"Ma","year":"2023","journal-title":"J. Neurol."},{"issue":"S1","key":"10.1016\/j.ejpn.2024.09.005_bib20","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barre syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2024.09.005_bib21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of guillain-barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejpn.2024.09.005_bib22","article-title":"Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort","author":"Broers","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"5","key":"10.1016\/j.ejpn.2024.09.005_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0883073811420872","article-title":"Autonomic dysfunction in childhood guillain-barr\u00e9 syndrome","volume":"27","author":"DiMario","year":"2012","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.09.005_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10286-018-0542-y","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: an update","volume":"29","author":"Zaeem","year":"2019","journal-title":"Clin. Auton. Res."},{"issue":"8093","key":"10.1016\/j.ejpn.2024.09.005_bib25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2024.09.005_bib26","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207282","article-title":"Cerebrospinal fluid findings in relation to clinical characteristics, subtype, and disease course in patients with guillain-barr\u00e9 syndrome","author":"Al-Hakem","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2024.09.005_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/mus.24667","article-title":"Acute-onset chronic inflammatory demyelinating polyneuropathy: an electrodiagnostic study","volume":"52","author":"Anadani","year":"2015","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ejpn.2024.09.005_bib28","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/ene.14497","article-title":"Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies","volume":"27","author":"Shibuya","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2024.09.005_bib29","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000013139","article-title":"Predicting outcome in guillain-barr\u00e9 syndrome: international validation of the modified erasmus GBS outcome score","volume":"98","author":"Doets","year":"2022","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ejpn.2024.09.005_bib30","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s10072-023-06802-z","article-title":"Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review","volume":"44","author":"Rzepi\u0144ski","year":"2023","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.ejpn.2024.09.005_bib31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/WNL.0b013e3182494d66","article-title":"Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Figueroa","year":"2012","journal-title":"Neurology"},{"issue":"7997","key":"10.1016\/j.ejpn.2024.09.005_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06916-6","article-title":"Autoreactive T cells target peripheral nerves in Guillain-Barr\u00e9 syndrome","volume":"626","author":"S\u00faken\u00edkov\u00e1","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejpn.2024.09.005_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/818570","article-title":"Gamma-Glutamyltransferase: a predictive biomarker of cellular antioxidant inadequacy and disease risk","volume":"2015","author":"Koenig","year":"2015","journal-title":"Dis. Markers"},{"issue":"10","key":"10.1016\/j.ejpn.2024.09.005_bib34","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/cns.13909","article-title":"Elevated gamma-glutamyl transferase levels are associated with stroke recurrence after acute ischemic stroke or transient ischemic attack","volume":"28","author":"Li","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejpn.2024.09.005_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.msard.2017.09.021","article-title":"Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis","volume":"18","author":"Shu","year":"2017","journal-title":"Mult Scler Relat Dis"},{"issue":"1","key":"10.1016\/j.ejpn.2024.09.005_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12987-020-0173-2","article-title":"Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient","volume":"17","author":"Castellazzi","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"10.1016\/j.ejpn.2024.09.005_bib37","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001031","article-title":"Interleukin 8, a biomarker to differentiate guillain-barr\u00e9 syndrome from CIDP","volume":"8","author":"Breville","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"10.1016\/j.ejpn.2024.09.005_bib38","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/ene.15428","article-title":"Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies","volume":"29","author":"Kmezic","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2024.09.005_bib39","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s13311-019-00716-5","article-title":"Differentiation between guillain-barr\u00e9 syndrome and acute-onset chronic inflammatory demyelinating polyradiculoneuritis-a prospective follow-up study using ultrasound and neurophysiological measurements","volume":"16","author":"Grimm","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"Pt 8","key":"10.1016\/j.ejpn.2024.09.005_bib40","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/brain\/awu158","article-title":"Early identification of \u201cacute-onset\u201d chronic inflammatory demyelinating polyneuropathy","volume":"137","author":"Sung","year":"2014","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ejpn.2024.09.005_bib41","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3233\/JND-230052","article-title":"Nerve conduction differences in a large clinical population: the role of age and sex","volume":"10","author":"Shelly","year":"2023","journal-title":"J. Neuromuscul. Dis."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982400148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982400148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T01:09:26Z","timestamp":1732928966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109037982400148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"alternative-id":["S109037982400148X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.09.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early differential diagnosis between acute inflammatory demyelinating polyneuropathy and acute-onset chronic inflammatory demyelinating polyneuropathy in children: Clinical factors and routine biomarkers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2024.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}